Propafenone efficacy in paroxysmal atrial fibrillation

Propafenone efficacy in paroxysmal atrial fibrillation

Efficacy and safety of class IС antiarrhythmic agent, propafenone, was investigated in patients with paroxysmal atrial fibrillation (PAF), after single-dose load and during long-term preventive treatment. The study included 20 male and female patients (mean age 53,8+2,4 years). PAF was caused by cor...

Full description

Saved in:

Bibliographic Details
Main Authors:	V. V. Skibitsky, E. A. Kudryashov, N. A. Spiropulos, A. M. Kramskaya, Z. T. Sokaeva
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2004-12-01
Series:	Российский кардиологический журнал
Subjects:	antiarrhythmics propafenone paroxysmal atrial fibrillation preventive therapy
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/2328
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Propafenone and amiodarone efficacy in paroxysmal atrial fibrillation treatment
by: N. N. Isakova, et al.
Published: (2006-06-01)

THE PROPANORM EFFICACY IN RAPID RELIEF OF SYMPTOMS OF PAROXYSMAL AURICULAR FIBRILLATION
by: N. N. Borovkov, et al.
Published: (2003-10-01)

Propafenone efficacy in treatment of atrial fibrillation paroxysms: a placebo-controlled study
by: Yu. A. Bunin, et al.
Published: (2005-12-01)

Endothelial function changes in paroxysmal atrial fibrillation and treatment with propafenone
by: V. I. Podzolkov, et al.
Published: (2018-08-01)

Propafenone in complex anti-recurrent therapy of persistent atrial fibrillation
by: V. V. Skibitsky, et al.
Published: (2007-08-01)

Propafenone in restoring sinus rhythm among patients with persistent atrial fibrillation. PROMETEY – an open, multicenter, pilot study performed in the Russian Federation
by: I. G. Fomina, et al.
Published: (2005-08-01)

ANTIARRHYTHMIC EFFICACY OF PROPAFENONE IN PATIENTS WITH PERSISTENT ATRIAL FIBRILLATION
by: R. D. Kurbanov, et al.
Published: (2016-01-01)

POSSIBLE PREDICTORS OF ATRIAL FIBRILLATION RECURRENCE IN LONG-TERM PROPHYLACTIC PROPAFENONE THERAPY
by: R. D. Kurbanov, et al.
Published: (2015-12-01)

Effectiveness of Class IC Antiarrhythmics in Patients with Paroxysmal Form of Atrial Fibrillation in Absence of Structural Heart Disease
by: D. A. Tsaregorodtsev, et al.
Published: (2023-05-01)

EFFECT OF SPIRAPRIL ON THE LENGTH OF INTERICTAL INTERVAL IN PAROXYSMAL ATRIAL FIBRILLATION
by: L. N. Chikhireva, et al.
Published: (2015-12-01)

Comparing the Impact of Different Antiarrhythmic Classes on Clinical Outcomes Following Atrial Fibrillation Catheter Ablation
by: Andrej Belančić, et al.
Published: (2025-07-01)

Propafenone effect on inotropic myocardial function in patients with recurrent atral fibrillation
by: I. G. Fomina, et al.
Published: (2006-06-01)

Propafenone and lisinopril therapy effectiveness for sinus rhythm maintenance in patients with persistent atrial fibrillation and arterial hypertension (PROMETEY-III)
by: R. G. Oganov, et al.
Published: (1970-01-01)

Predictors of paroxysmal thyrotoxic atrial fibrillation
by: L. N. Berestennikova, et al.
Published: (2011-10-01)

Propafenone efficacy and safety in restoring and maintaining sinus rhythm in patients with recurrent atrial fibrillation: results of the open, prospective placebo-controlled trial
by: I. G. Fomina, et al.
Published: (2005-04-01)

Preliminary results of a prospective randomized study comparing the efficacy and safety of refralon and amiodarone in cardioversion in patients with paroxysmal atrial fibrillation and flutter
by: D. A. Gagloeva, et al.
Published: (2023-05-01)

An economic evaluation of first-line cryoballoon ablation versus antiarrhythmic drug therapy for the treatment of paroxysmal atrial fibrillation from a German healthcare payer perspective
by: Malte Kuniss, et al.
Published: (2024-11-01)

Hearing the Vagus Nerve’s Rhythm in Patients with Paroxysmal Atrial Fibrillation
by: A. A. Nechepurenko, et al.
Published: (2020-07-01)

EFFECTIVENESS AND SAFETY OF PROPAFENONE (PROPANORM®) AND AMIODARONE (CORDARONE®) IN PATIENTS WITH ATRIAL FIBRILLATION, ARTERIAL HYPERTENSION, CORONARY HEART DISEASE, AND CHRONIC HEART FAILURE WITH INTACT LEFT VENTRICULAR SYSTOLIC FUNCTION
by: O. N. Miller, et al.
Published: (2010-08-01)

Propafenone in restoring sinus rhythm among patients with persistent atrial fibrillation. PROMETEY – an open, multicenter, pilot study performed in the Russian Federation (part II)
by: I. G. Fomina, et al.
Published: (2005-10-01)

COMPARISON OF TREATMENT EFFICACY IN PAROXYSMAL ATRIAL FIBRILLATION
by: V. G. Tregubov, et al.
Published: (2017-04-01)

Paroxysmal atrial fibrillation: treatment choice
by: B. A. Tatarsky
Published: (2007-06-01)

ADJUSTMENT OF PHARMACOLOGICAL ANTIARRHYTHMIC THERAPY IN PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION DURING SERIAL TESTING OF ANTIARRHYTHMIC DRUGS WITH TRANSESOPHAGEAL ELECTROPHYSIOLOGICAL STUDIES
by: K. A. Skiba, et al.
Published: (2003-06-01)

PAROXYSMAL ATRIAL FIBRILLATION: CHOICE OF CARDIOVERSION THERAPY
by: B. A. Tatarskii
Published: (2015-12-01)

ANALYSIS OF THE RESULTS OF FIVE YEAR PATIENTS FOLLOW-UP IN PAROXYSMAL ATRIAL FIBRILLATION TREATED WITH ANTIARRHYTHMICS
by: T. A. Rybakova, et al.
Published: (2018-08-01)

STRUCTURAL AND ELECTROPHYSIOLOGICAL PREDICTORS OF A PAROXYSM OF ATRIAL FIBRILLATION
by: B. G. Iskenderov, et al.
Published: (2001-08-01)

Tactics of Antiarrhythmic Therapy in Comorbid Elderly and Senile Patients with Paroxysmal and Recurrent Atrial Fibrillation
by: M. H. Fedorova, et al.
Published: (2018-11-01)

Heart rate variability and trans-esophageal atrial stimulation data in predicting recurrent atrial fibrillation paroxysms
by: T. V. Setyn, et al.
Published: (2007-12-01)

Antiarrhythmic therapy in the treatment of atrial fibrillation: yesterday, today, tomorrow
by: V. I. Podzolkov, et al.
Published: (2019-06-01)

ATRIAL FIBRILLATION: CURRENT PROBLEMS AND PROSPECTS OF MEDICAL CARE, TREATMENT AND PREVENTION
by: Ju. P. Skirdenko, et al.
Published: (2016-05-01)

Experience of using propafenone in newborns and young children with arrhythmias
by: T. K. Kruchina, et al.
Published: (2020-08-01)

Prevention of atrial fibrillation episodes in patients with chronic heart failure: a new approach to the old problem
by: Yu. M. Pozdnyakov, et al.
Published: (1970-01-01)

CARDIOVERSION WITH BI- AND MONOPHASE DEFIBRILLATORS IN PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION
by: V. A. Lusov, et al.
Published: (2010-02-01)

Distribution Patterns of Paroxysmal Atrial Fibrillation Triggers and Catheter Ablation Success Rates
by: Dongsheng Zhao, et al.
Published: (2025-03-01)

Personalized Medicine in the Treatment of Atrial Fibrillation: Myth or Reality?
by: V. I. Podzolkov, et al.
Published: (2019-03-01)

Maintenance and Reversibility of Paroxysmal Atrial Fibrillation in JDP2 Overexpressing Mice
by: Gerhild Euler, et al.
Published: (2025-07-01)

Fluid retention in patients with paroxysmal and permanent atrial fibrillation and heart failure
by: V. V. Kirillova, et al.
Published: (2020-11-01)

PROSPECTS FOR THE TREATMENT OF PATIENTS WITH ATRIAL FIBRILLATION
by: V. A. Sulimov, et al.
Published: (2016-01-01)

Machine-learning model for predicting left atrial thrombus in patients with paroxysmal atrial fibrillation
by: Wanli Xiong, et al.
Published: (2025-06-01)

Mechanisms of paroxysmal atrial fibrillation in patients with sick sinus syndrome
by: S. Yu. Ivanov, et al.
Published: (2004-08-01)